LANNETT CO INC FDA Approval ANDA 091342

ANDA 091342

LANNETT CO INC

FDA Drug Application

Application #091342

Application Sponsors

ANDA 091342LANNETT CO INC

Marketing Status

Prescription001

Application Products

001SOLUTION;ORALEQ 4MG BASE/5ML0ONDANSETRON HYDROCHLORIDEONDANSETRON HYDROCHLORIDE

FDA Submissions

ORIG1AP2011-01-27
LABELING; LabelingSUPPL3AP2015-01-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2016-03-03UNKNOWN
LABELING; LabelingSUPPL5AP2018-03-14STANDARD
LABELING; LabelingSUPPL6AP2018-03-14STANDARD
LABELING; LabelingSUPPL8AP2022-06-23STANDARD
SUPPL27AP2011-01-27

Submissions Property Types

ORIG1Null7
SUPPL3Null15
SUPPL4Null7
SUPPL5Null7
SUPPL6Null7
SUPPL8Null7
SUPPL27Null0

TE Codes

001PrescriptionAA

CDER Filings

LANNETT CO INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91342
            [companyName] => LANNETT CO INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ONDANSETRON HYDROCHLORIDE","activeIngredients":"ONDANSETRON HYDROCHLORIDE","strength":"EQ 4MG BASE\/5ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ONDANSETRON HYDROCHLORIDE","submission":"ONDANSETRON HYDROCHLORIDE","actionType":"EQ 4MG BASE\/5ML","submissionClassification":"SOLUTION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.